
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy
Marie Siwicki, Nicolas A. Gort-Freitas, Marius Messemaker, et al.
Science Immunology (2021) Vol. 6, Iss. 61
Open Access | Times Cited: 63
Marie Siwicki, Nicolas A. Gort-Freitas, Marius Messemaker, et al.
Science Immunology (2021) Vol. 6, Iss. 61
Open Access | Times Cited: 63
Showing 1-25 of 63 citing articles:
Clinical relevance of tumour-associated macrophages
Mikaël J. Pittet, Olivier Michielin, Denis Migliorini
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 402-421
Closed Access | Times Cited: 460
Mikaël J. Pittet, Olivier Michielin, Denis Migliorini
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 402-421
Closed Access | Times Cited: 460
Liver macrophages in health and disease
Martin Guilliams, Charlotte L. Scott
Immunity (2022) Vol. 55, Iss. 9, pp. 1515-1529
Open Access | Times Cited: 221
Martin Guilliams, Charlotte L. Scott
Immunity (2022) Vol. 55, Iss. 9, pp. 1515-1529
Open Access | Times Cited: 221
Neutrophil phenotypes and functions in cancer: A consensus statement
Daniela F. Quail, Borko Amulic, Monowar Aziz, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 6
Open Access | Times Cited: 208
Daniela F. Quail, Borko Amulic, Monowar Aziz, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 6
Open Access | Times Cited: 208
A neutrophil response linked to tumor control in immunotherapy
Jeremy Gungabeesoon, Nicolas A. Gort-Freitas, Máté Kiss, et al.
Cell (2023) Vol. 186, Iss. 7, pp. 1448-1464.e20
Closed Access | Times Cited: 203
Jeremy Gungabeesoon, Nicolas A. Gort-Freitas, Máté Kiss, et al.
Cell (2023) Vol. 186, Iss. 7, pp. 1448-1464.e20
Closed Access | Times Cited: 203
Why nanoparticles prefer liver macrophage cell uptake in vivo
Wayne Ngo, Sara Ahmed, Colin Blackadar, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114238-114238
Closed Access | Times Cited: 141
Wayne Ngo, Sara Ahmed, Colin Blackadar, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114238-114238
Closed Access | Times Cited: 141
The nuclear factor ID3 endows macrophages with a potent anti-tumour activity
Zihou Deng, Pierre-Louis Loyher, Tomi Lazarov, et al.
Nature (2024) Vol. 626, Iss. 8000, pp. 864-873
Open Access | Times Cited: 23
Zihou Deng, Pierre-Louis Loyher, Tomi Lazarov, et al.
Nature (2024) Vol. 626, Iss. 8000, pp. 864-873
Open Access | Times Cited: 23
Clinical landscape of macrophage-reprogramming cancer immunotherapies
Jenna H. Rannikko, Maija Hollmén
British Journal of Cancer (2024) Vol. 131, Iss. 4, pp. 627-640
Open Access | Times Cited: 17
Jenna H. Rannikko, Maija Hollmén
British Journal of Cancer (2024) Vol. 131, Iss. 4, pp. 627-640
Open Access | Times Cited: 17
Heterogeneity and Function of Kupffer Cells in Liver Injury
Weiyang Li, Na Chang, Liying Li
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 63
Weiyang Li, Na Chang, Liying Li
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 63
Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting
Ran Salomon, Hagar Rotem, Yonatan Katzenelenbogen, et al.
Nature Cancer (2022) Vol. 3, Iss. 3, pp. 287-302
Closed Access | Times Cited: 48
Ran Salomon, Hagar Rotem, Yonatan Katzenelenbogen, et al.
Nature Cancer (2022) Vol. 3, Iss. 3, pp. 287-302
Closed Access | Times Cited: 48
Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy
Ran Salomon, Rony Dahan
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41
Ran Salomon, Rony Dahan
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41
Neutrophils in host defense, healing, and hypersensitivity: Dynamic cells within a dynamic host
Marie Siwicki, Paul Kubes
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 3, pp. 634-655
Closed Access | Times Cited: 30
Marie Siwicki, Paul Kubes
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 3, pp. 634-655
Closed Access | Times Cited: 30
The roles of tissue resident macrophages in health and cancer
Minmin Cao, Zihao Wang, Wanying Lan, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Minmin Cao, Zihao Wang, Wanying Lan, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Advanced insights on tumor-associated macrophages revealed by single-cell RNA sequencing: The intratumor heterogeneity, functional phenotypes, and cellular interactions
Sen Yang, Mengyi Wang, Yuze Hua, et al.
Cancer Letters (2024) Vol. 584, pp. 216610-216610
Closed Access | Times Cited: 9
Sen Yang, Mengyi Wang, Yuze Hua, et al.
Cancer Letters (2024) Vol. 584, pp. 216610-216610
Closed Access | Times Cited: 9
In vivo armed macrophages curb liver metastasis through tumor-reactive T-cell rejuvenation
Marco Notaro, Marco Borghetti, Chiara Bresesti, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Marco Notaro, Marco Borghetti, Chiara Bresesti, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Emerging Biomaterials Imaging Antitumor Immune Response
Xianbin Ma, Meng‐Jie Zhang, Jingting Wang, et al.
Advanced Materials (2022) Vol. 34, Iss. 42
Closed Access | Times Cited: 29
Xianbin Ma, Meng‐Jie Zhang, Jingting Wang, et al.
Advanced Materials (2022) Vol. 34, Iss. 42
Closed Access | Times Cited: 29
Tissue-resident macrophages exacerbate lung injury after remote sterile damage
Hanhui Zhong, Jingjing Ji, Jinling Zhuang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 4, pp. 332-348
Closed Access | Times Cited: 6
Hanhui Zhong, Jingjing Ji, Jinling Zhuang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 4, pp. 332-348
Closed Access | Times Cited: 6
IL-2-mediated hepatotoxicity: knowledge gap identification based on the irAOP concept
Luise A. Roser, Christina Sakellariou, Malin Lindstedt, et al.
Journal of Immunotoxicology (2024) Vol. 21, Iss. sup1
Open Access | Times Cited: 6
Luise A. Roser, Christina Sakellariou, Malin Lindstedt, et al.
Journal of Immunotoxicology (2024) Vol. 21, Iss. sup1
Open Access | Times Cited: 6
Dual Immunostimulatory Pathway Agonism through a Synthetic Nanocarrier Triggers Robust Anti‐Tumor Immunity in Murine Glioblastoma
Sophie Lugani, Elias A. Halabi, Juhyun Oh, et al.
Advanced Materials (2022) Vol. 35, Iss. 7
Open Access | Times Cited: 28
Sophie Lugani, Elias A. Halabi, Juhyun Oh, et al.
Advanced Materials (2022) Vol. 35, Iss. 7
Open Access | Times Cited: 28
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events
Alexander Coukos, Julien Vionnet, Michel Obéid, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 10, pp. e005635-e005635
Open Access | Times Cited: 23
Alexander Coukos, Julien Vionnet, Michel Obéid, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 10, pp. e005635-e005635
Open Access | Times Cited: 23
Harnessing the potential of CD40 agonism in cancer therapy
Yang Zhou, Ann Richmond, Chi Yan
Cytokine & Growth Factor Reviews (2023) Vol. 75, pp. 40-56
Open Access | Times Cited: 16
Yang Zhou, Ann Richmond, Chi Yan
Cytokine & Growth Factor Reviews (2023) Vol. 75, pp. 40-56
Open Access | Times Cited: 16
Versatile neutrophil functions in cancer
Marie Siwicki, Mikaël J. Pittet
Seminars in Immunology (2021) Vol. 57, pp. 101538-101538
Open Access | Times Cited: 32
Marie Siwicki, Mikaël J. Pittet
Seminars in Immunology (2021) Vol. 57, pp. 101538-101538
Open Access | Times Cited: 32
Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?
Nathan Karin
Cancers (2021) Vol. 13, Iss. 24, pp. 6317-6317
Open Access | Times Cited: 27
Nathan Karin
Cancers (2021) Vol. 13, Iss. 24, pp. 6317-6317
Open Access | Times Cited: 27
The double‐edged role of neutrophil heterogeneity in inflammatory diseases and cancers
Wencheng Zhou, Xinran Cao, Qiang Xu, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 11
Wencheng Zhou, Xinran Cao, Qiang Xu, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 11
A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors
Giulia Rotta, Ettore Gilardoni, Domenico Ravazza, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 4, pp. 904-926
Open Access | Times Cited: 4
Giulia Rotta, Ettore Gilardoni, Domenico Ravazza, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 4, pp. 904-926
Open Access | Times Cited: 4
Myeloid cells in the microenvironment of brain metastases
Nian Chen, Tao Zhang, Xianyan Yang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189311-189311
Closed Access
Nian Chen, Tao Zhang, Xianyan Yang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189311-189311
Closed Access